| Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery L Pascucci, V Coccè, A Bonomi, D Ami, P Ceccarelli, E Ciusani, L Viganò, ... Journal of controlled release 192, 262-270, 2014 | 838 | 2014 |
| Mesenchymal stem/stromal cells: a new''cells as drugs''paradigm. Efficacy and critical aspects in cell therapy L de Girolamo, E Lucarelli, G Alessandri, M Antonietta Avanzini, ... Current pharmaceutical design 19 (13), 2459-2473, 2013 | 218 | 2013 |
| Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells A Del Fattore, R Luciano, R Saracino, G Battafarano, C Rizzo, L Pascucci, ... Expert opinion on biological therapy 15 (4), 495-504, 2015 | 175 | 2015 |
| Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy A Pessina, A Bonomi, V Coccè, G Invernici, S Navone, L Cavicchini, ... PloS one 6 (12), e28321, 2011 | 175 | 2011 |
| Application of the CFU-GM assay to predict acute drug-induced neutropenia: an international blind trial to validate a prediction model for the maximum tolerated dose (MTD) of … A Pessina, B Albella, M Bayo, J Bueren, P Brantom, S Casati, C Croera, ... Toxicological sciences 75 (2), 355-367, 2003 | 157 | 2003 |
| Prevalidation of a model for predicting acute neutropenia by colony forming unit granulocyte/macrophage (CFU-GM) assay A Pessina, B Albella, J Bueren, P Brantom, S Casati, L Gribaldo, C Croera, ... Toxicology in vitro 15 (6), 729-740, 2001 | 143 | 2001 |
| Decellularized silk fibroin scaffold primed with adipose mesenchymal stromal cells improves wound healing in diabetic mice SE Navone, L Pascucci, M Dossena, A Ferri, G Invernici, F Acerbi, ... Stem cell research & therapy 5, 1-15, 2014 | 135 | 2014 |
| Mesenchymal stem/stromal cell extracellular vesicles: From active principle to next generation drug delivery system B Crivelli, T Chlapanidas, S Perteghella, E Lucarelli, L Pascucci, AT Brini, ... Journal of Controlled Release 262, 104-117, 2017 | 131 | 2017 |
| Pancreas developing markers expressed on human mononucleated umbilical cord blood cells A Pessina, B Eletti, C Croera, N Savalli, C Diodovich, L Gribaldo Biochemical and Biophysical Research Communications 323 (1), 315-322, 2004 | 115 | 2004 |
| Ex vivo expanded mesenchymal stromal cell minimal quality requirements for clinical application ML Torre, E Lucarelli, S Guidi, M Ferrari, G Alessandri, L De Girolamo, ... Stem cells and development 24 (6), 677-685, 2015 | 86 | 2015 |
| Mesenchymal stromal cells primed with P aclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia‐bearing mice A Pessina, V Coccè, L Pascucci, A Bonomi, L Cavicchini, F Sisto, ... British journal of haematology 160 (6), 766-778, 2013 | 85 | 2013 |
| The key role of adult stem cells: therapeutic perspectives A Pessina, L Gribaldo Current Medical Research and Opinion 22 (11), 2287-2300, 2006 | 85 | 2006 |
| Angiogenic and anti-inflammatory properties of micro-fragmented fat tissue and its derived mesenchymal stromal cells V Ceserani, A Ferri, A Berenzi, A Benetti, E Ciusani, L Pascucci, ... Vascular cell 8, 1-12, 2016 | 84 | 2016 |
| Human mesenchymal stromal cells inhibit tumor growth in orthotopic glioblastoma xenografts S Pacioni, QG D’Alessandris, S Giannetti, L Morgante, V Coccè, A Bonomi, ... Stem Cell Research & Therapy 8, 1-15, 2017 | 79 | 2017 |
| Immortalization of human adipose-derived stromal cells: production of cell lines with high growth rate, mesenchymal marker expression and capability to secrete high levels of … L Balducci, A Blasi, M Saldarelli, A Soleti, A Pessina, A Bonomi, V Coccè, ... Stem cell research & therapy 5, 1-15, 2014 | 74 | 2014 |
| Mesenchymal stromal cells loaded with paclitaxel induce cytotoxic damage in glioblastoma brain xenografts S Pacioni, QG D’Alessandris, S Giannetti, L Morgante, I De Pascalis, ... Stem cell research & therapy 6, 1-11, 2015 | 73 | 2015 |
| Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study A Bonomi, A Silini, E Vertua, PB Signoroni, V Coccè, L Cavicchini, F Sisto, ... Stem cell research & therapy 6, 1-10, 2015 | 71 | 2015 |
| Drug Loaded Gingival Mesenchymal Stromal Cells (GinPa-MSCs) Inhibit In Vitro Proliferation of Oral Squamous Cell Carcinoma V Coccè, D Farronato, AT Brini, C Masia, AB Giannì, G Piovani, F Sisto, ... Scientific Reports 7 (1), 9376, 2017 | 67 | 2017 |
| Hematotoxicity testing by cell clonogenic assay in drug development and preclinical trials A Pessina, I Malerba, L Gribaldo Current pharmaceutical design 11 (8), 1055-1065, 2005 | 66 | 2005 |
| The Use of In Vitro Systems for Evaluating Haematotoxicity: The Report and Recommendations of ECVAM Workshop 14, L Gribaldo, J Bueren, A Deldar, P Hokland, C Meredith, D Moneta, ... Alternatives to Laboratory animals 24 (2), 211-231, 1996 | 61 | 1996 |
